Holdings of BVF INC/IL
35 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 66.8 % of the equity sleeve
Sector breakdown
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 99.6 %
- CH 0.2 %
- FR 0.1 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|
| US | 33 | 2.5B $ | 99.64 % |
| CH | 1 | 5.4M $ | 0.21 % |
| FR | 1 | 3.8M $ | 0.15 % |
Positions
| Company | Shares | Value | Weight |
|---|
| Kymera Therapeutics Inc | 5,502,710 | 458.3M $ | |
| Revolution Medicines Inc | 2,856,782 | 277.8M $ | |
| Nektar Therapeutics | 2,559,595 | 184.2M $ | |
| Structure Therapeutics Inc | 3,459,358 | 166.7M $ | |
| Mirum Pharmaceuticals Inc | 1,584,727 | 146.4M $ | |
| Palvella Therapeutics Inc | 960,989 | 119.8M $ | |
| Zymeworks Inc | 3,734,142 | 93.5M $ | |
| Xencor Inc | 7,133,720 | 86M $ | |
| Stoke Therapeutics Inc | 2,547,557 | 82.9M $ | |
| Cullinan Therapeutics Inc | 5,750,683 | 81.7M $ | |
| Disc Medicine Inc | 1,272,312 | 81.4M $ | |
| XOMA Royalty Corp | 2,590,303 | 81.3M $ | |
| Olema Pharmaceuticals Inc | 5,295,893 | 79M $ | |
| Tyra Biosciences Inc | 1,976,196 | 75.7M $ | |
| Monte Rosa Therapeutics Inc | 4,460,886 | 73.4M $ | |
| Kura Oncology Inc | 8,445,769 | 68.7M $ | |
| Annexon Inc | 8,698,173 | 48.2M $ | |
| Compass Therapeutics Inc | 7,764,842 | 41.1M $ | |
| Immunocore Holdings PLC | 1,294,463 | 39M $ | |
| Septerna Inc | 1,353,249 | 32.5M $ | |
| Sutro Biopharma Inc | 1,251,788 | 31.2M $ | |
| Foghorn Therapeutics Inc | 5,842,000 | 27.9M $ | |
| 4D Molecular Therapeutics Inc | 2,879,289 | 26.8M $ | |
| Invivyd Inc | 19,525,000 | 25.4M $ | |
| AVALO THERAPEUTICS INC | 1,632,845 | 24.4M $ | |
| Eledon Pharmaceuticals Inc | 6,293,282 | 19.4M $ | |
| Anteris Technologies Global Corp | 3,000,000 | 16.7M $ | |
| X4 PHARMACEUTICALS INC | 2,233,742 | 9.2M $ | |
| IMMUNIC INC | 7,652,972 | 8.5M $ | |
| OnKure Therapeutics Inc | 1,978,972 | 8.2M $ | |
| TScan Therapeutics Inc | 5,564,290 | 5.6M $ | |
| IMAGENEBIO INC | 1,110,002 | 5.6M $ | |
| Tenax Therapeutics Inc | 339,549 | 5.4M $ | |
| MOLECULAR PARTNERS AG | 1,353,968 | 5.4M $ | |
| Inventiva SACA | 686,040 | 3.8M $ | |